IL123189A0 - Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides - Google Patents
Colon cell and colon cancer cell associated nucleic acid molecules protein and peptidesInfo
- Publication number
- IL123189A0 IL123189A0 IL12318996A IL12318996A IL123189A0 IL 123189 A0 IL123189 A0 IL 123189A0 IL 12318996 A IL12318996 A IL 12318996A IL 12318996 A IL12318996 A IL 12318996A IL 123189 A0 IL123189 A0 IL 123189A0
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- protein
- colon
- nucleic acid
- acid molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51187695A | 1995-08-24 | 1995-08-24 | |
| US08/597,495 US5712369A (en) | 1995-08-24 | 1996-02-02 | Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein |
| PCT/US1996/012699 WO1997008189A1 (en) | 1995-08-24 | 1996-08-05 | Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123189A0 true IL123189A0 (en) | 1998-09-24 |
Family
ID=27057377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12318996A IL123189A0 (en) | 1995-08-24 | 1996-08-05 | Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5712369A (de) |
| EP (1) | EP0851870B1 (de) |
| AT (1) | ATE365744T1 (de) |
| AU (1) | AU701105B2 (de) |
| CA (1) | CA2229028C (de) |
| DE (1) | DE69637148T2 (de) |
| IL (1) | IL123189A0 (de) |
| WO (1) | WO1997008189A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39760E1 (en) | 1988-03-31 | 2007-08-07 | International Bio-Immune Systems Inc. | Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| US6312921B1 (en) | 1996-07-26 | 2001-11-06 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| AU6537798A (en) * | 1997-03-14 | 1998-10-12 | Denise Casentini-Borocz | Targeted cytolysis of cancer cells |
| CA2287872C (en) * | 1997-05-12 | 2010-07-27 | Aphton Corporation | Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| US20040001842A1 (en) * | 1997-05-12 | 2004-01-01 | Dov Michaeli | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors |
| EP1241180B1 (de) * | 1998-03-20 | 2008-07-30 | Genentech, Inc. | Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure |
| EP1080106A1 (de) * | 1998-05-18 | 2001-03-07 | Genetics Institute, Inc. | Ausgeschiedene proteine und für diese kodierende polynukleotide |
| US6346249B1 (en) | 1999-10-22 | 2002-02-12 | Ludwig Institute For Cancer Research | Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products |
| US6342587B1 (en) | 1999-10-22 | 2002-01-29 | Ludwig Institute For Cancer Research | A33 antigen specific immunoglobulin products and uses thereof |
| JP2005508838A (ja) * | 2001-03-23 | 2005-04-07 | アフトン コーポレーション | 膵癌の組合せ治療 |
| US20090191232A1 (en) * | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
| AU2002326356A1 (en) * | 2001-07-09 | 2003-01-29 | Aphton Corporation | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| WO2004088326A2 (en) * | 2003-03-28 | 2004-10-14 | Aphton Corporation | Gastrin hormone immunoassays |
| US20060020119A1 (en) * | 2004-03-29 | 2006-01-26 | Stephen Grimes | Monoclonal antibodies to gastrin hormone |
| AT500651B9 (de) * | 2003-05-27 | 2010-04-15 | Altropus Gmbh | Aktiv immunisierender antikörper |
| EP1794586B1 (de) | 2004-09-22 | 2013-01-30 | Cancer Advances, Inc., | Monoklonale antikörper gegen progastrin |
| US7314622B2 (en) | 2005-04-15 | 2008-01-01 | Neogenix Oncology, Inc. | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| JP5710978B2 (ja) * | 2007-11-08 | 2015-04-30 | ネオジェニックス オンコロジー, インコーポレイテッド | 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原 |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| CA2803391C (en) | 2010-06-22 | 2021-11-09 | Neogenix Oncology, Inc. | Npc1 antibodies that bind a muc5ac epitope |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US12150978B2 (en) | 2017-06-15 | 2024-11-26 | Cancer Advances Inc. | Compositions and methods for preventing tumors and cancer |
| KR102772810B1 (ko) | 2017-06-15 | 2025-02-28 | 캔서 어드밴시스 아이엔씨 | 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법 |
| US12285437B2 (en) | 2019-10-30 | 2025-04-29 | The Research Foundation For The State University Of New York | Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579827A (en) * | 1983-03-11 | 1986-04-01 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
| PT628077E (pt) * | 1992-12-10 | 2002-07-31 | Celltech Therapeutics Ltd | Anticorpos humanizados direccionados contra o antigenio de a33 |
-
1996
- 1996-02-02 US US08/597,495 patent/US5712369A/en not_active Expired - Lifetime
- 1996-08-05 AT AT96928049T patent/ATE365744T1/de active
- 1996-08-05 EP EP96928049A patent/EP0851870B1/de not_active Expired - Lifetime
- 1996-08-05 DE DE69637148T patent/DE69637148T2/de not_active Expired - Lifetime
- 1996-08-05 CA CA002229028A patent/CA2229028C/en not_active Expired - Fee Related
- 1996-08-05 US US09/068,051 patent/US6291235B1/en not_active Expired - Lifetime
- 1996-08-05 AU AU67650/96A patent/AU701105B2/en not_active Ceased
- 1996-08-05 WO PCT/US1996/012699 patent/WO1997008189A1/en not_active Ceased
- 1996-08-05 IL IL12318996A patent/IL123189A0/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5712369A (en) | 1998-01-27 |
| WO1997008189A1 (en) | 1997-03-06 |
| DE69637148D1 (de) | 2007-08-09 |
| EP0851870A1 (de) | 1998-07-08 |
| AU701105B2 (en) | 1999-01-21 |
| US6291235B1 (en) | 2001-09-18 |
| ATE365744T1 (de) | 2007-07-15 |
| CA2229028C (en) | 2008-06-10 |
| DE69637148T2 (de) | 2008-04-30 |
| AU6765096A (en) | 1997-03-19 |
| EP0851870B1 (de) | 2007-06-27 |
| CA2229028A1 (en) | 1997-03-06 |
| EP0851870A4 (de) | 2000-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0851870A4 (de) | Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen | |
| RU94045919A (ru) | Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция | |
| BR9707379A (pt) | Anticorpo humano isolado ácido nucleico isolado vetor recombinante de expressão célula hospedeira processo para sintetizar um anticorpo humano que se liga á TNF Alfa humano composição farmacéutica processo para inibir á atividade do TNF humano e uso do anticorpo | |
| AU6063500A (en) | Glycoprotein vi and uses thereof | |
| CY1112334T1 (el) | Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων | |
| ATE353365T1 (de) | Neue b7-4 moleküle und deren verwendungen | |
| EP1053245A4 (de) | 45 menschliche sekretierte proteine | |
| EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
| SE9201331D0 (sv) | Protein l och hybridproteiner daerav | |
| ATE301716T1 (de) | Vmp-ähnliche sequenzen von pathogener borrelia | |
| EP1009752A4 (de) | Neue moleküle aus der familieder tango-77-ähnlichen proteine und ihre verewendungen. | |
| EP1015477A4 (de) | 32 durch menschen ausgeschüttete proteine | |
| AU3217100A (en) | Methods of use of a novel lysyl oxidase-related protein | |
| GB9207949D0 (en) | Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility | |
| DK0877803T3 (da) | OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder | |
| WO2000073323A3 (en) | Adam polynucleotides and polypeptides | |
| WO1996031603A3 (en) | Methods and compositions for regulating fadd | |
| EP0815240A4 (de) | Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
| EP1042342A4 (de) | 53 proteine menschlichen ursprungs | |
| EP0369816A3 (de) | Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper | |
| WO2000061774A3 (en) | Bone morphogenic proteins | |
| WO1995008628A3 (en) | Nucleic acids encoding merosin, merosin fragments and uses thereof | |
| ATE302214T1 (de) | Enamel-matrix bezogene polypeptide | |
| WO2001000673A8 (en) | Membrane-associated and secreted proteins and uses thereof | |
| WO2004078918A3 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |